3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Lung Neoplasms
2
Esophageal Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sjogren's Syndrome
1
Scleroderma, Systemic
1
Retinoblastoma
1
Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)
1
Resectable Non-small Cell Lung Cancer
1
Resectable Lung Non-Small Cell Carcinoma
1
Recurrence
1
Psoriasis
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Sclerosis
1
Lupus Erythematosus, Systemic
1
Inflammatory Bowel Diseases
1
Hematologic Neoplasms
1
Dermatomyositis
1
Crohn Disease
1
Colitis, Ulcerative
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Bronchogenic
1
Bronchial Neoplasms
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthritis, Psoriatic
1
Advanced Non-small Cell Lung Cancer
1
Interventions
Cyclophosphamide
21
venetoclax
18
pembrolizumab
16
Dexamethasone
16
fludarabine
14
Cytarabine
13
Gemcitabine
9
pomalidomide
8
Rituximab
8
Carboplatin
8
Azacitidine
8
glofitamab
7
fludarabine phosphate
7
Lenalidomide
7
Immunotherapy, Adoptive
7
selinexor
6
Paclitaxel
6
Injections
6
Granulocyte Colony-Stimulating Factor
6
Cisplatin
6
daratumumab
5
Temozolomide
5
Oxaliplatin
5
Bevacizumab
5
zanubrutinib
4
ruxolitinib
4
Surgical Procedures, Operative
4
Nivolumab
4
Drug Therapy
4
Decitabine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Recurrence
×
Platinum Compounds
×
Clear all
NCT07340164
2026-04-20
TROY
Yonsei University
Phase 2
Recruiting
116 enrolled